Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Current tobacco smoking and risk from COVID-19: results from a population symptom app in over 2.4 million people

View ORCID ProfileNicholas S Hopkinson, Niccolò Rossi, Julia S El-Sayed Moustafa, Anthony A Laverty, Jennifer K Quint, View ORCID ProfileMaxim B Freidin, Alessia Visconti, Benjamin Murray, Marc Modat, Sebastien Ourselin, Kerrin Small, Richard Davies, Jonathan Wolf, Tim D Spector, Claire J Steves, Mario Falchi
doi: https://doi.org/10.1101/2020.05.18.20105288
Nicholas S Hopkinson
1National Heart and Lung Institute, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas S Hopkinson
  • For correspondence: n.hopkinson@ic.ac.uk mario.falchi@kcl.ac.uk
Niccolò Rossi
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia S El-Sayed Moustafa
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony A Laverty
3School of Public Health, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer K Quint
1National Heart and Lung Institute, Imperial College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxim B Freidin
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maxim B Freidin
Alessia Visconti
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Murray
4School of Biomedical Engineering & Imaging Sciences, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Modat
4School of Biomedical Engineering & Imaging Sciences, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastien Ourselin
4School of Biomedical Engineering & Imaging Sciences, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerrin Small
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Davies
5Zoe Global Ltd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Wolf
5Zoe Global Ltd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim D Spector
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire J Steves
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Falchi
2The Department of Twin Research & Genetic Epidemiology, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n.hopkinson@ic.ac.uk mario.falchi@kcl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

SUMMARY

Background The association between current tobacco smoking, the risk of developing COVID-19 and the severity of illness is an important information gap.

Methods UK users of the COVID Symptom Study app provided baseline data including demographics, anthropometrics, smoking status and medical conditions, were asked to log symptoms daily from 24th March 2020 to 23rd April 2020. Participants reporting that they did not feel physically normal were taken through a series of questions, including 14 potential COVID-19 symptoms and any hospital attendance. The main study outcome was the association between current smoking and the development of “classic” symptoms of COVID-19 during the pandemic defined as fever, new persistent cough and breathlessness. The number of concurrent COVID-19 symptoms was used as a proxy for severity. In addition, association of subcutaneous adipose tissue expression of ACE2, both the receptor for SARS-CoV-2 and a potential mediator of disease severity, with smoking status was assessed in a subset of 541 twins from the TwinsUK cohort.

Results Data were available on 2,401,982 participants, mean(SD) age 43.6(15.1) years, 63.3% female, overall smoking prevalence 11.0%. 834,437 (35%) participants reported being unwell and entered one or more symptoms. Current smokers were more likely to develop symptoms suggesting a diagnosis of COVID-19; classic symptoms adjusted OR[95%CI] 1.14[1.10 to 1.18]; >5 symptoms 1.29[1.26 to 1.31]; >10 symptoms 1.50[1.42 to 1.58]. Smoking was associated with reduced ACE2 expression in adipose tissue (Beta(SE)=-0.395(0.149); p=7.01×10-3).

Interpretation These data are consistent with smokers having an increased risk from COVID-19.

Funding Zoe provided in kind support for all aspects of building, running and supporting the app and service to all users worldwide. The study was also supported by grants from the Wellcome Trust, UK Research and Innovation and British Heart Foundation.

Evidence before this study The interaction between current smoking and COVID-19 is unclear. Smoking is known to increase susceptibility to viral infections and appears to be associated with worse outcomes in people admitted to hospital with COVID-19. However, case series have reported relatively low levels of current smoking among individuals admitted to hospital with the condition, raising the possibility that smoking has a protective effect against the disease.

Added value of this study Data from a large UK population who are users of a symptom reporting app during the pandemic supports the hypothesis that smokers are more likely to develop symptoms consistent with COVID-19 and that they have an increased symptom burden.

Implications of all the available evidence These population data, combined with evidence of a worse outcome in smokers hospitalised with the condition, support the contention that smoking increases individual risk from COVID-19. Support to help people to quit smoking should therefore form part of efforts to deal with the pandemic.

Competing Interest Statement

NSH is Chair of Action on Smoking and Health and Medical Director of The British Lung Foundation. TDS is a consultant to Zoe Global Ltd (Zoe) who developed the app. J W and RD are or employees of Zoe Global Limited. Other authors have no conflict of interest to declare.

Clinical Trial

n/a

Funding Statement

This work was supported by Zoe Global Limited as well as grants from the Wellcome Trust (212904/Z/18/Z) and the Medical Research Council (MRC)/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY; MR/M016560/1). TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, Chronic Disease Research Foundation (CDRF), Zoe Global Ltd and the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. JSES, TDS and KSS acknowledge support from the Medical Research Council (MR/M004422/1).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Joint first author

Data Availability

Anonymised research data will be shared with third parties via the centre for Health Data Research UK (HDRUK.ac.uk). Data updates can be found on https://COVID.joinzoe.com TwinsUK RNASeq gene expression data used in this study are available under EGA accession number EGAS00001000805.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 21, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Current tobacco smoking and risk from COVID-19: results from a population symptom app in over 2.4 million people
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Current tobacco smoking and risk from COVID-19: results from a population symptom app in over 2.4 million people
Nicholas S Hopkinson, Niccolò Rossi, Julia S El-Sayed Moustafa, Anthony A Laverty, Jennifer K Quint, Maxim B Freidin, Alessia Visconti, Benjamin Murray, Marc Modat, Sebastien Ourselin, Kerrin Small, Richard Davies, Jonathan Wolf, Tim D Spector, Claire J Steves, Mario Falchi
medRxiv 2020.05.18.20105288; doi: https://doi.org/10.1101/2020.05.18.20105288
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Current tobacco smoking and risk from COVID-19: results from a population symptom app in over 2.4 million people
Nicholas S Hopkinson, Niccolò Rossi, Julia S El-Sayed Moustafa, Anthony A Laverty, Jennifer K Quint, Maxim B Freidin, Alessia Visconti, Benjamin Murray, Marc Modat, Sebastien Ourselin, Kerrin Small, Richard Davies, Jonathan Wolf, Tim D Spector, Claire J Steves, Mario Falchi
medRxiv 2020.05.18.20105288; doi: https://doi.org/10.1101/2020.05.18.20105288

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8786)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10563)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1755)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1844)
  • Public and Global Health (3985)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)